FDA panel approves multi-cancer early detection test | ChicagoLIVE

Radiation oncologist Dr. Kevin King discusses a new generation of multi-cancer early detection (MCED) blood tests. While an advisory panel has recommended approval, the FDA has not yet officially cleared it. The test aims to detect over 50 types of cancer, including those currently lacking adequate screening, though it is intended to complement rather than replace standard screenings.